Evidence map›Paper›PMID 30665939›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Upregulation of Chitinase 1 in Alveolar Macrophages of HIV-Infected Smokers.

Eric C Logue, C Preston Neff, Douglas G Mack, Allison K Martin, Suzanne Fiorillo, James Lavelle, R William Vandivier, Thomas B Campbell, Brent E Palmer, Andrew P Fontenot

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Chronic obstructive pulmonary disease in HIV.Expert review of respiratory medicine · 2021
    Review
  6. Article
  7. Review
  8. Chitotriosidase: a marker and modulator of lung disease.European respiratory review : an official journal of the European Respiratory Society · 2020
    Review
  9. Looking Higher: Is It Prime Time for the Oral-Lung Axis in HIV-related Lung Disease?American journal of respiratory and critical care medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Eric C LogueDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
C Preston NeffDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
Douglas G MackDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
Allison K MartinDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
Suzanne FiorilloDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
James LavelleDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
R William VandivierDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
Thomas B CampbellDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.
Brent E PalmerDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and.ORCID 0000-0001-6932-065X
Andrew P FontenotDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; and andrew.fontenot@ucdenver.edu.ORCID 0000-0003-4095-512X
University of Colorado Anschutz Medical Campus · US

Funding

Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung diseaseU01HL121816 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI CAMPBELL, THOMAS B., FONTENOT, ANDREW P. · 2013 to 2017
$3.4M
HIV-associated gut microbiome affects lung immunity and pneumococcal immune responseR01HL138639 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI CAMPBELL, THOMAS B., LOZUPONE, CATHERINE · 2017 to 2020
$1.9M
Patient-Oriented Research in Immunologic Lung Disease.K24HL102245 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2010 to 2020
$1.4M
NCATS NIH HHS UL1 TR000154NHLBI NIH HHS K24 HL102245NHLBI NIH HHS R01 HL138639NHLBI NIH HHS U01 HL121816
6 · The paper itself

Abstract

Recent studies suggest that HIV infection is an independent risk factor for the development of chronic obstructive pulmonary disease (COPD). We hypothesized that HIV infection and cigarette smoking synergize to alter the function of alveolar macrophages (AMs). To test this hypothesis, global transcriptome analysis was performed on purified AMs from 20 individuals split evenly between HIV-uninfected nonsmokers and smokers and untreated HIV-infected nonsmokers and smokers. Differential expression analysis identified 143 genes significantly altered by the combination of HIV infection and smoking. Of the differentially expressed genes, chitinase 1 (CHIT1) and cytochrome P450 family 1 subfamily B member 1 (CYP1B1), both previously associated with COPD, were among the most upregulated genes (5- and 26-fold, respectively) in the untreated HIV-infected smoker cohort compared with HIV-uninfected nonsmokers. Expression of CHIT1 and CYP1B1 correlated with the expression of genes involved in extracellular matrix organization, oxidative stress, immune response, and cell death. Using time-of-flight mass cytometry to characterize AMs, a significantly decreased expression of CD163, an M2 marker, was seen in HIV-infected subjects, and CD163 inversely correlated with CYP1B1 expression in AMs. CHIT1 protein levels were significantly upregulated in bronchoalveolar lavage fluid from HIV-infected smokers, and increased CHIT1 levels negatively correlated with lung function measurements. Overall, these findings raise the possibility that elevated CHIT1 and CYP1B1 are early indicators of COPD development in HIV-infected smokers that may serve as biomarkers for determining this risk.

Indexed as

Up-RegulationAdultBiomarkersFemaleHexosaminidasesHIV InfectionsHumansMacrophages, AlveolarMaleMiddle AgedPulmonary Disease, Chronic ObstructiveSmokersYoung AdultBiomarkerschitotriosidaseHexosaminidases

Identifiers

PMID30665939
PMCPMC6382585
OpenAlexW2911157043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.